Skip to main content

Table 3 Demographic Data

From: The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery

  MB Group
n = 311
Non-MB Group
n = 202
p-value
Age [years] 65.7 ± 12.0 65.8 ± 11.4 n.s.
Male 243 [78] 163 [81] n.s.
BMI [kg/m2] 31.7 ± 57.8 27.7 ± 6.5 n.s.
ASA
1–2 5 [2] 8 [4] 0.001
3 136 [46] 122 [60]  
4 138 [47] 67 [33]  
5 12 [4] 1 [1]  
Nicotine Abuse 94 [32] 71 [35] n.s.
Coronary Heart Disease 191 [65] 144 [71] n.s.
With Stent 22 [7] 11 [5] n.s.
Angina Pectoris 67 [23] 79 [39] 0.001
Previous Myocardial Infarction 81 [27] 35 [17] 0.009
NYHA
1 1 [0.3] 0 0.014
2 15 [5] 7 [4]  
3 162 [56] 143 [71]  
4 106 [36] 47 [23]  
Left Ventricular Ejection Fraction [%] 47.5 ± 18.8 45.8 ± 17. n.s.
Pacemaker 23 [8] 13 [6] n.s.
Hypertension 203 [69] 147 [75] n.s.
Peripheral Arterial Disease 47 [16] 36 [18] n.s.
With Stent 25 [8] 17 [8] n.s.
Pulmonary Hypertension 30 [10] 16 [8] n.s.
Renal Failure
GFR > 89 mL/min 35 [11] 42 [21] 0.004
GFR 60–89 64 [21] 58 [29]  
GFR 30–59 59 [19] 38 [19]  
GFR < 30 29 [9] 9 [5]  
Dialysis 1 [0.3] 0  
Cerebrovascular Events 20 [7] 6 [3] n.s.
Allergy 54 [18] 39 [19] n.s.
  1. BM Body mass index, ASA American Society of Anesthesiologists, NYHA New York Heart Association, GFR Glomerular filtration rate; All data are presented as number [%] or mean +/− SD. n.s.: not significant